Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia

被引:33
作者
Luesink, Maaike [1 ]
Jansen, Joop H. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Haematol Lab, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands
关键词
acute promyelocytic leukaemia; differentiation therapy; adhesion molecules; integrins; chemokines; corticosteroids; TRANS-RETINOIC ACID; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACUTE LUNG INJURY; PML-RAR-ALPHA; RESPIRATORY-DISTRESS-SYNDROME; RISK-ADAPTED TREATMENT; TUMOR-SUPPRESSOR PTEN; CELL LINE NB-4; ARSENIC TRIOXIDE; NEUTROPHIL ELASTASE;
D O I
10.1111/j.1365-2141.2010.08325.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>In acute promyelocytic leukaemia (APL), differentiation therapy can be complicated by the development of a differentiation syndrome (DS). Pulmonary infiltration of differentiating leukaemic cells is a key event in the development of DS. Several mediators have been identified that may promote migration and extravasation of differentiating APL cells from the bloodstream into the tissue. Adhesion of APL cells to each other and to the endothelium is induced by upregulation of the expression of adhesion molecules and constitutively active beta 2-integrins during differentiation therapy. The expression of chemokines and their receptors is significantly upregulated as well. Pulmonary chemokine production can trigger transendothelial migration of differentiating APL cells from the bloodstream into the underlying tissue (initiation phase of DS). Massive production of chemokines by infiltrated APL cells can further enhance transendothelial migration of differentiating APL cells, causing an uncontrollable hyperinflammatory reaction in the lung (aggravation phase), which is not efficiently switched-off by corticosteroids.
引用
收藏
页码:209 / 220
页数:12
相关论文
共 96 条
  • [1] Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    Asou, N
    Adachi, K
    Tamura, J
    Kanamaru, A
    Kageyama, S
    Hiraoka, A
    Omoto, E
    Akiyama, H
    Tsubaki, K
    Saito, K
    Kuriyama, K
    Oh, H
    Kitano, K
    Miyawaki, S
    Takeyama, K
    Yamada, O
    Nishikawa, K
    Takahashi, M
    Matsuda, S
    Ohtake, S
    Suzushima, H
    Emi, N
    Ohno, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 78 - 85
  • [2] A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:: The Japan Adult Leukemia Study Group (JALSG) APL97 study
    Asou, Norio
    Kishimoto, Yuji
    Kiyoi, Hitoshi
    Okada, Masaya
    Kawai, Yasukazu
    Tsuzuki, Motohiro
    Horikawa, Kentaro
    Matsuda, Mitsuhiro
    Shinagawa, Katsuji
    Kobayashi, Tohru
    Ohtake, Shigeki
    Nishimura, Miki
    Takahashi, Masatomo
    Yagasaki, Fumiharu
    Takeshita, Akihiro
    Kimura, Yukihiko
    Lwanaga, Masako
    Naoe, Tomoki
    Ohno, Ryuzo
    [J]. BLOOD, 2007, 110 (01) : 59 - 66
  • [3] CCL2/CCR2: push/pull for migration
    Avvisati, Giuseppe
    [J]. BLOOD, 2009, 114 (27) : 5411 - 5412
  • [4] Acute monocytic leukemia presenting as acute respiratory failure
    Azoulay, É
    Fieux, F
    Moreau, D
    Thiery, G
    Rousselot, P
    Parrot, A
    Le Gall, JR
    Dombret, H
    Schlemmer, B
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1329 - 1333
  • [5] Bacon K, 2002, J INTERF CYTOK RES, V22, P1067
  • [6] Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury
    Bao, ZhiYao
    Ye, QingWei
    Gong, WangHua
    Xiang, Yi
    Wan, HuanYing
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (02) : 259 - 263
  • [7] Differentiation associated modulation of the cytokine and chemokine expression pattern in human myeloid cell lines
    Behringer, D
    Schaufler, J
    Kresin, V
    Lübbert, M
    Lindemann, A
    [J]. LEUKEMIA RESEARCH, 2001, 25 (02) : 141 - 149
  • [8] Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
    Bertini, R
    Allegretti, M
    Bizzarri, C
    Moriconi, A
    Locati, M
    Zampella, G
    Cervellera, MN
    Di Cioccio, V
    Cesta, MC
    Galliera, E
    Martinez, FO
    Di Bitondo, R
    Troiani, G
    Sabbatini, V
    D'Anniballe, G
    Anacardio, R
    Cutrin, JC
    Cavalieri, B
    Mainiero, F
    Strippoli, R
    Villa, P
    Di Girolamo, M
    Martin, F
    Gentile, M
    Santoni, A
    Corda, D
    Poli, G
    Mantovani, A
    Ghezzi, P
    Colotta, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) : 11791 - 11796
  • [9] Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
    Bhatia, M
    Moochhala, S
    [J]. JOURNAL OF PATHOLOGY, 2004, 202 (02) : 145 - 156
  • [10] Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin
    Breccia, Massimo
    Latagliata, Roberto
    Carmosino, Ida
    Cannella, Laura
    Diverio, Daniela
    Guarini, Anna
    De Propris, Maria Steania
    Petti, Maria Concetta
    Avvisati, Giuseppe
    Cimino, Giuseppe
    Mandelli, Franco
    Lo-Coco, Francesco
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1918 - 1920